our why

Pelvic Venous Disease

Pelvic venous disease (PVD) presents a significant challenge in the realm of healthcare, often serving as an elusive culprit behind chronic pelvic pain and a myriad of associated symptoms. Unfortunately, it frequently evades detection, leading patients down a frustrating path of multiple physician consultations, years of enduring discomfort, and a range of treatments, including pelvic floor physical therapy and procedures that may yield little to no relief. 

The array of symptoms linked to pelvic venous disease stems from elevated vein pressure, and without intervention, these symptoms can exacerbate over time. Complicating matters further, patients may harbor various vein issues simultaneously, making diagnosis and treatment particularly complex. 

Adding to the complexity, there may be an increased incidence of PVD in patients with connective tissue disorders such as Ehlers-Danlos syndrome, mast cell activation syndrome, and chronic fatigue syndrome. These underlying conditions can exacerbate symptoms and complicate treatment approaches, underscoring the importance of a comprehensive understanding of each patient’s medical history and potential contributing factors. 

Despite the debilitating impact of PVD on patients’ lives, insurance coverage for treatments targeting ovarian veins has been hesitant, citing inconsistent outcomes across studies and the variable expertise of physicians. However, recent findings have shed light on a previously overlooked contributor: blockage in the main vein draining the leg and pelvis. Surprisingly, this discovery has revealed it to be a more substantial factor in symptom manifestation than the previously presumed sole cause of pelvic congestion—reversed blood flow in the ovarian vein. 

In light of these revelations, it is imperative to advocate for expanded insurance coverage and research efforts to address the multifaceted nature of pelvic venous disease comprehensively. Through increased awareness, rigorous investigation, and targeted interventions, we endeavor to alleviate the suffering of individuals afflicted by this often misunderstood condition, restoring hope and improving quality of life. 

 

45% of women ages 19-64 reported delaying or skipping medical care because of financial barriers.

This includes essential services such as preventive screenings, treatments, and vaccinations. The inability to afford out-of-pocket expenses was the most commonly cited reason for forgoing care.

These findings highlight the ongoing challenges many women face in accessing necessary healthcare services, underscoring the need for policies aimed at improving affordability and reducing financial obstacles to care.

Pelvic Venous Disease in Numbers

PVD accounts for approximately 16% to 31% of cases of chronic pelvic pain without an alternative diagnosis.
As of 2022, about 9.8% of nonelderly adult women (ages 18–64) in the U.S. were uninsured.
12% of insured individuals between the ages of 19 and 64 are considered underinsured, meaning their medical expenses after insurance (excluding premiums) represent 10% or more of their incomes.

Research & Educational Resources

Sorem ipsum dolor sit amet, consectetur

Morem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum.

Sorem ipsum dolor sit amet, consectetur

Morem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum.

Sorem ipsum dolor sit amet, consectetur

Morem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum.

DONATE

Lasting Contributions

Donations make care accessible, provide needed support for research, and aid in raising awareness through education.